Oscar Health, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Oscar Health, Inc. on December 17, 2021. The report details significant changes in executive leadership roles and the appointment of a new Chief Legal Officer.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
- Role Transition: Joel Klein transitioned from Chief Policy and Strategy Officer to Senior Advisor to the Chief Executive Officer effective December 17, 2021.
- Compensation Adjustment: An amended and restated employment agreement for Mr. Klein, effective January 1, 2022, sets his annual salary at $100,000.
- Severance Terms: In the event of termination without cause, Mr. Klein is entitled to six months of cash severance and continued healthcare coverage, subject to specific covenants.
- New Appointment: Ranmali Bopitiya is appointed as Chief Legal Officer, effective January 31, 2022.
Outlook, Risks, and Management Commentary
Management expressed a commitment to continuing work with Mr. Klein in his new advisory capacity. Ms. Bopitiya brings over fifteen years of healthcare industry experience, including prior roles as Chief Legal Officer at Everside Health and General Counsel for the Colorado Permanente Medical Group. The filing does not disclose specific risks, contingencies, or unusual items beyond the standard terms of the employment agreements.
Key Facts for Investor Verification
- Verify the effective date of Ranmali Bopitiya's appointment as Chief Legal Officer (January 31, 2022).
- Confirm the specific terms of the "termination without cause" clause in Mr. Klein's new agreement.
- Review subsequent filings for any impact of these leadership changes on the company's strategic direction.